반응 #1779953

ord-03a4c91261e04da086da6570ec19fd26

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    기타The product was purified by reverse phase HPLC

실험 절차

5-Chloro-2-(4-methanesulfonyl-piperazin-1-ylmethyl)-7-morpholin-4-yl-thiazolo[5,4-d]pyrimidine (130 mg) was reacted with 92 mg of 3-(4,4,5,5-tetramethyl-1,3,2,-dioxaborolan-2-yl)quinoline via General Procedure A. The product was purified by reverse phase HPLC to yield 72.6 mg of 112. MS (Q1) 526.2 (M)+.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US08158626B2uspto-grants-2012_04